Pregabalin poisoning: Evaluation of dose-toxicity relationship.

clinical toxicology intoxication overdose poisoning pregabalin toxicity

Journal

British journal of clinical pharmacology
ISSN: 1365-2125
Titre abrégé: Br J Clin Pharmacol
Pays: England
ID NLM: 7503323

Informations de publication

Date de publication:
03 2022
Historique:
revised: 19 08 2021
received: 15 07 2021
accepted: 24 08 2021
pubmed: 11 9 2021
medline: 27 4 2022
entrez: 10 9 2021
Statut: ppublish

Résumé

Pregabalin poisoning is mostly benign, although coma and convulsions occasionally occur. To determine the dose-toxicity relationship of pregabalin. Dose-toxicity data of isolated pregabalin poisonings were collected from (1) a prospective study performed by the Dutch Poisons Information Centre (4 April 2014 to 4 October 2016) and from (2) case reports and case series reported in literature. Poisonings were graded using the Poisoning Severity Score (PSS) and the relationship between dose (mg kg In our study (n = 21 patients), the most commonly observed symptoms were drowsiness (62%), confusion (29%) and apathy (24%). PSS was none in three (14%), minor in 15 (71%), and moderate in three patients (14%). Most case series also reported a PSS of none to minor in the majority of poisonings (69-100%). For 34 individual patients (21 from our study and 13 from literature), detailed data on dose and clinical course were available to examine the dose-toxicity relationship. The median dose was significantly lower in the PSS none-minor group ("benign") (8.6 mg kg In general, higher pregabalin doses result in more severe poisonings. Below 20 mg kg

Identifiants

pubmed: 34505299
doi: 10.1111/bcp.15073
pmc: PMC9293434
doi:

Substances chimiques

Pregabalin 55JG375S6M

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1288-1297

Informations de copyright

© 2021 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.

Références

Expert Rev Neurother. 2016 Nov;16(11):1263-1277
pubmed: 27345098
J Toxicol Clin Toxicol. 1998;36(3):205-13
pubmed: 9656975
Br J Clin Pharmacol. 2022 Mar;88(3):1288-1297
pubmed: 34505299
BMJ. 1995 Aug 5;311(7001):376-80
pubmed: 7640549
Clin Toxicol (Phila). 2021 May;59(5):433-439
pubmed: 33006482
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571
BMJ. 2020 Apr 28;369:m1315
pubmed: 32345589
Clin Neuropharmacol. 2017 Sep/Oct;40(5):226-228
pubmed: 28922287
Drugs. 2017 Mar;77(4):403-426
pubmed: 28144823
Int Clin Psychopharmacol. 2017 Jan;32(1):49-55
pubmed: 27643884
Turk J Ophthalmol. 2018 Oct;48(5):254-257
pubmed: 30405948
J Med Toxicol. 2010 Dec;6(4):435-7
pubmed: 20373065
Br J Clin Pharmacol. 2020 Dec;86(12):2435-2440
pubmed: 32374500
J Med Toxicol. 2014 Sep;10(3):254-60
pubmed: 24515527

Auteurs

Saskia J Rietjens (SJ)

Dutch Poisons Information Center, University Medical Center Utrecht, Utrecht University, the Netherlands.

Maaike A Sikma (MA)

Dutch Poisons Information Center, University Medical Center Utrecht, Utrecht University, the Netherlands.
Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht University, the Netherlands.

Claudine C Hunault (CC)

Dutch Poisons Information Center, University Medical Center Utrecht, Utrecht University, the Netherlands.

Dylan W de Lange (DW)

Dutch Poisons Information Center, University Medical Center Utrecht, Utrecht University, the Netherlands.
Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht University, the Netherlands.

Laura Hondebrink (L)

Dutch Poisons Information Center, University Medical Center Utrecht, Utrecht University, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH